Early Cytokine Signatures Predict COVID Severity and May Guide Interventions

According to this new Nature paper, those with severe COVID are spiking higher cytokine signatures early on. This would suggest value in testing, including possibly IFN-gamma (see below), and addressing it early through anti-inflammatory diet and lifestyle, as well as targeted anti-inflammatory nutraceutical interventions. This is, of course, a ‘standard’ approach used in Functional Medicine,…

covid-19 new research

COVID Antibodies Decline, But The Question About Lasting Immunity is Still Unanswered

Protective antibodies against COVID-19 may only last a short time after infection, new evidence shows. However, it doesn’t mean that scientists have definitively answered the question about lasting immunity for this particular virus. The current thinking is that even low levels of powerful neutralizing antibodies may still be protective – after all, the immune system…

Blood Pressure Medications Don’t Increase Risk for Severe COVID-According to New Wuhan Data Analysis

Potential good news for those with high blood pressure… taking antihypertensive medication, including ACE-inhibitors and ARBs, does not seem to increase the risk of more severe COVID-19 infection. This is based on a collective meta-analysis of group data from Wuhan, China reported in the European Heart Journal. This had previously been a potential concern since…

Scientific Papers Retracted from One of the World’s Most Prestigious Journals

Last week, the prestigious medical journal, The Lancet, retracted two COVID-19-related papers. One of those papers had reported on negative effects of hydroxycloroquine as a potential treatment option, leading to much controversy over the use of the drug. The reason for the retraction? Surgisphere Corporation, the company providing the underlying database of information that was…